李 璐,张长荣,曹海霞

支原体肺炎是儿童常见的呼吸道感染性疾病之一，尤其在5岁以上儿童中发病率较高。近年来，随着抗生素耐药性的增加和疾病复杂性的提升，单纯依赖现代医学治疗儿童支原体肺炎的效果受到限制。中西医结合模式通过整合中医整体调理和西医精准治疗的优势，逐渐成为治疗儿童支原体肺炎的重要策略。本文旨在通过梳理近年来有关中西医治疗儿童支原体肺炎的相关文献，探讨中西医结合模式在支原体肺炎治疗中的应用及临床效果，进一步为临床治疗提供参考，促进支原体肺炎的早期诊断和治疗，提高患儿的生存质量。

儿童；肺炎支原体肺炎；中西医治疗

[1] 中华医学会儿科学分会呼吸学组､《中华儿科杂志》编辑委员会.儿童社区获得性肺炎管理指南(2013修订)(上)[J].中华儿科杂志, 2013,51(10):745-752. [2] Atkinson TP,Balish MF,Waites KB.Epidemiology,clinical manifestations,pathogenes isand laboratory detection of Mycoplasma pneumoniae infections[J].FEMS Microbiol R ev,2008,32:956-973. [3] Balish M F,Santurri R T,Ricci,et al.Localization of Mycoplasma pneumoniae cyt adherence-associatedprotein HMW2 by fusion with green fluorescent protein:impl ications for attachment organelle structure[J].Mol Microbiol,2003,47:49-60. [4] Kannan T R,Provenzano D,Wright J R,et al.Identification and Characterization of Human Surfactant Protein A Binding Protein of Mycoplasma pneumoniae[J].Infection&Immunity,2005,73(5):2828-2834. [5] Kannan TR,Baseman JB.ADP-ribosylating and vacuolating cytotoxin of Mycopl asmapneumoniae represents unique viru Lence determinant among bacterial pat hogens[J].Proc Natl Acad-Sci USA,2006,103(11):6724-6729. [6] Takeshi Saraya,Daisuke Kurai,Kazuhide Nakagaki,et al.Novel aspects on the pathogenesis of Mycoplasma pneumoniae pneumonia and therapeutic implications[J].Frontiers in Microbiology,2014,5(410):410. [7] Kurata S,Osaki T,Yonezawa Het al.Role IL-17A and IL-10 in the antigen induc ed inflammation model by Mycoplasma pneumoniae[J]. BMC Microbiology,2014,14(1):156. [8] 柯红,邝咏云.小儿肺炎支原体感染后免疫功能变化的探讨[J].中外医疗,2017,36(1):24-25. [9] 冯妍.支原体肺炎感染后免疫球蛋白及补体表达量的变化趋势研究[J].中国医药指南,2016,14(22):162-163. [10] 阚倩娜,姜之炎.中医中药抑制肺炎支原体机制的研究探讨[J].中华中医药学刊,201 9,37(03):658-660. [11] Yavlovich A,Katzenell A,Tarshis M,et al.Mycoplasma fermen tans binds to and inad es HeLa cells:involvement of plasminogen and urokinase[J].Infect Immun,2004,72(9):5 004-5011. [12] 刘瀚旻,马融.儿童肺炎支原体肺炎中西医结合诊治专家共识(2017年制定)[J].中国实用儿科杂志,2017,32(12):881-885. [13] GUO D X,HU W J,WEI R,et al.Epidemiology and mechanism of drug resistance of Mycoplasma pneumoniae in Beijing,China:a multicenter study[J].Bosn J Basic Med Sci,2019,19(3):288-296. [14] GUO Z L,LIU L Y,GONG J,et al.Molecular features and antimicrobial susceptibility of Mycoplasma pneumoniae isolates from paediatric inpatients in Weihai,China:charac teristics of M.pneumoniae in Weihai[J].Glob Antimicrob Resist,2022,28:180-184. [15] 陈佳怡,张晗,尚云晓.肺炎支原体肺炎支气管肺泡灌洗液中23SrRNA耐药基因阳性患儿的临床及支气管镜下特点[J].中华实用儿科临床杂志,2022,37(12):897-902. [16] Zhu Z,Zhang T,Guo W,Ling Y,Tian J,Xu Y.Clinical characteristics of refractory mycoplasma pneumoniae pneumonia in children treated with glucocorticoid pulse ther apy[J].BMC Infect Dis,2021,21(1):126. [17] 廖尚秋,谭惠,张雪梅,等.海南省2012-2020年小儿肺炎支原体感染多中心流行病学特征分析[J].中国热带医学.2023, 23(5):511-515,533. [18] 张雅迪,林俊,王丽琼,等.甲泼尼龙琥珀酸钠联合阿奇霉素治疗难治性支原体肺炎患儿的疗效及对血NLR､PLR水平的影响[J].北方药学,2023,20(6):139-141. [19] 孙爽爽.人血丙种球蛋白联合糖皮质激素对难治性肺炎支原体肺炎患儿T淋巴细胞亚群和炎性指标水平的影响[J].中国民康医学,2021,33(8):120-121. [20] 赵菁,徐大荣.甲泼尼龙联合吸入型糖皮质激素对儿童难治性肺炎支原体肺炎的疗效分析[J].中国社区医师,2021,37(28):78-79. [21] 廖震.丙种球蛋白联合阿奇霉素治疗小儿肺炎支原体肺炎的疗效及对C反应蛋白､免疫球蛋白水平的影响[J].中国妇幼保健, 2018.33(6):1324-1327. [22] 王淑叶,张文波,万瑜.存在肺实变的肺炎支原体肺炎患儿行支气管肺泡灌洗术的预测模型构建[J].中国当代儿科杂志,2023, 25(10):1052-1058. [23] 丁志远.纤维支气管镜肺泡灌洗辅助治疗小儿重症支原体肺炎的临床效果研究[J].中国实用医药,2023,18(18):57-60. [24] 姜永红,虞坚尔,姜之炎,等.从“肺络”探讨小儿支原体肺炎的防治[J].天津中医药,2012,29(1):52-53. [25] 吴振起,刘光华,王子,等.从燥论治儿童肺炎支原体肺炎临床经验[J].中国中西医结合儿科学,2012,4(6):508-510. [26] 陈慧.儿童支原体肺炎的中西医结合研究[D].北京:北京中医药大学,2010. [27] 蒋加强,季新明.阿奇霉素联合穴位敷贴治疗小儿支原体肺炎疗效观察[J].新中医,2015,47(1):161-162. [28] 袁园春,周华,汪彩虹.阿奇霉素联合推拿治疗小儿肺炎65例临床观察[J].中国民族民间医药,2015,24(20):50-52.

点击下载PDF